Evidence map›Paper›PMID 36768377›Full record

ArticleInternational journal of molecular sciences2023

Protective Effects of

Tianhua He, Nikita Lykov, Xu Luo, Huiling Wang, Zhanxiang Du, Ziyi Chen, Shitian Chen, Lin Zhu, Ye Zhao, Chimeng Tzeng

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tianhua HeSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.
Nikita LykovSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.ORCID 0000-0003-1040-1927
Xu LuoSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.
Huiling WangSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.
Zhanxiang DuSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.
Ziyi ChenSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.
Shitian ChenSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.
Lin ZhuSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.
Ye ZhaoSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.ORCID 0000-0002-2852-7432
Chimeng TzengSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, China.
Nanjing Tech University · CN

Funding

National Natural Science Foundation of China 31701279
6 · The paper itself

Abstract

Fatty liver is one of the most pervasive liver diseases worldwide. Probiotics play an important role in the progression of liver disease, but their effects on host regulation are poorly understood. This study investigated the protective effects of lactobacillus gasseri (

Indexed as

Diet, High-FatFatty LiverLactobacillus gasseriProbioticsZebrafishAnimalsCholesterolDietGene Expression ProfilingGene Expression RegulationLarvaLipidsLiverPhosphatidylinositol 3-KinasesTranscriptomeCholesterolLipidsPhosphatidylinositol 3-Kinasesfatty liverhigh cholesterol dietIL-17Lactobacillus gasserizebrafish

Identifiers

PMID36768377
PMCPMC9917166
OpenAlexW4317529015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.